Keywords: study, suggests, tdm, at-risk, cellcept, patients, swiss

Study suggests TDM for at-risk CellCept patients

Article | 18 August 2008

Print This

Swiss drug major Roche presented data at the 22nd International Congress of the Transplantation Society, held in Sydney, Australia, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in